Interferon-gamma (IFN-γ) and P2X7 receptor are crucial for host defence against mycobacterial infections. Recent studies have indicated that IFN-γ, IFN-γ receptor 1 (IFN-γR1) andP2X7 gene polymorphisms are associated with susceptibility to pulmonary tuberculosis (TB). However, the relationship between IFN-γ and P2X7 polymorphism and TB susceptibility remains inconclusive in Iranian population. For this reason, single nucleotide polymorphisms (SNPs) in IFN-γ (G+2109A), IFN-γR1 (G-611A) and P2X7 genes (at -762, 1513 position) in patients (n = 100) were assessed using PCR-RFLP. Data were analysed with SPSS version 18. For the 2109 loci of IFN-γ gene, the frequency of mutant alleles between patients and controls were not statistically signifi cant. However, there was a signifi cant difference between the TB patient and controls for -611 alleles of IFN-γR1 (P = 0.01). Additionally, the frequency of P2X7 gene polymorphisms (SNP-762 and 1513) between patients and controls was statistically signifi cant. In conclusions, our study revealed a signifi cant association of IFN-γR1 and P2X7 genes polymorphisms with risk of developing TB in Iranian population.
Introduction
Tuberculosis (TB) caused by Mycobacterium tuberculosis (MTB) remains a major public health problem in the world. According to the latest report released by world health organization (WHO), approximately one-third of the world's population is infected with MTB, with an estimated 9.6 million new cases [1] .
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Among those who are infected, only 5-10% will develop the active form of the disease with clinical symptoms [1] . Other infected individuals may remain noninfectious and symptoms free for many years. Factors that control progression of disease are still poorly defi ned for the majority of cases reported. Genetic variability and some environmental factors are expected to contribute to the risk of developing active tuberculosis [2, 3] . Genetic variations such as polymorphisms in the genes encoding interferon-gamma (IFN-γ), P2X7 receptor, interleukin-12, and vitamin D3 receptor, which occur more commonly, are considered to account for the susceptibility of the general population to TB [4] [5] [6] . IFN-γ is a key T helper type 1 cytokine produced by natural killer cells and T cells [7] . Its production plays a pivotal role in macrophage activation for controlling mycobacterial infection [8] . Many studies have also shown that extracellular ATP, through the activation of the P2X7 purinergic receptor, induces bactericidal activity of macrophages [9, 10] . Recently, IFN-γ and P2X7 polymorphisms have been reported to be associated with pulmonary TB [7, 11] . For example, IFN-γ (-2109A/G) polymorphism was signifi cantly associated with pulmonary TB in Croatian and Chinese populations [12, 13] . In addition, P2X7 polymorphisms have been associated with TB in Gambian Population [11] . However, the association of IFN-γ and P2X7 gene polymorphisms and pulmonary TB is somewhat controversial in Iranian population. The aim of this study was to investigate the correlation of polymorphisms in IFN-γ (+2109A), IFN-γ receptor-1 (-611A) and P2X7 genes (-762 and 1513) in Iranian pulmonary TB patients.
Materials and Methods

Setting and study population
The study was conducted from January 2013 to December 2014, in the Mycobacteriology Research Center, Tehran, Iran. A total of 100 patients with culture-positive TB and 100 healthy volunteers (normal controls) were included in the study. The mean age of the patients and controls was 49 and 43 years, respectively. The male-to-female sex ratio was 1:2 (male/female: 33/67), with a similar distribution in both groups. The institutional review board at the center approved the study and all the patients have signed informed consent.
DNA extraction
Genomic DNA was extracted using the standard proto col with minor modifi cations [14] . Briefl y, peripheral blood leukocytes (PBLs) were separated from two millilitres of the whole blood using RBC lysis buffer (0.155 M NH4Cl, 0.01 M NaHCO3). Thereafter, PBLs were re-suspend ed in 500 μL of SE buffer (NaCl 3M, EDTA 0.5M, PH = 8), containing 40 μL of 10% SDS and 3 μL of 20 mg/mL of pro teinase K. The suspension was incubated at 60°C for 30 minutes. After incubation, 200 μL of equilibrated phenol (PH = 8) was added to the mixture and centrifuged for 10 minutes at 12 000 g. The aqueous phase was transferred to a new tube and the DNA was precipitated using cold propanol.
IFN-γ genotyping
Single-nucleotide polymorphisms (SNPs) in IFN-γ receptor-1 (G-611A), IFN-γ (G+2109A) were performed using PCR-RFLP. The target DNA was amplifi ed in a PCR reaction mixture containing 1× reaction buffer (50 mM KCl, 67 mM Tris-HCl [pH 9.0], 2 mM MgCl 2 ), 2 mM of dNTPs, 0.2 U of Taq DNApolymerase (Roch, Germany), and 20 pmol of each primers. For IFN-γ receptor-1G-611A, the following primers were used to amplify a 85 bp product: 5′ AGACAAACCCAGAGAGGTAAGAGA 3′; 5′ ACCTTCTCAGCAATTCAGT-GTCAAA 3′. For IFN-γ (G+2109A) polymorphisms, the following primers were used to amplify a 366 bp product; 5' AATCGCTGAAGTATGTAAT 3'; 5' GCATTGTAGAGTTTTG 3'. The PCR products of IFN-γ receptor-1 and IFN-γ were digested with 2 U enzymes of NIaIII and FauI, respectively. Digested products were run on 8% polyacrylamide gel and were stained with silver nitrate.
P2X7 genotyping
Polymorphisms in the P2X7 gene, namely P2X7 SNP-762 and 1513 were studied using PCR-RFLP. For P2X7 gene polymorphisms at -762 C/T allele, two outer primers (P2X73 [5'-GAAACAGGGCCCTGGGTCCTC-3', forward] and P2X74 [5'-TGGTGGGGGTGGAGGGGC-3', reverse]) and two inner primers (P2X75 [5'-GGTGTCCCTCACTGAATAGGTCAAT-3', forward and P2X76 [5'-GGCAGTCCAACAAAGTTAGGTTTG-3', reverse]) were used. The amplifi cation was accomplished by an initial denaturation at 94 °C for 5 minutes and 30 cycles at 95 °C for 30 seconds, at 65 °C for 30 seconds, at 72 °C for 45 seconds, followed by an extension at 72 °C for 10 minutes. The amplifi ed PCR products for CC, CT and TT had the following sizes 235 bp, 186+235 bp and 186 bp, respectively. For P2X7 gene polymorphisms at 1513, the primers 5′ ACTCCTAG ATCCAGGGATAGCC 3′ and 5′ TACAGACGTGAGCCACGGT 3′ were used to amplify the 417 bp product. The PCR product was digested with 4 U enzyme of Hae II. The di gested PCR products were run on 8% polyacrylamide gel, which was stained with ethidium bromide. The digest pattern for AA, AC and CC are as follows; 209+143+65 bp; 209+143+117+92+65 bp and 143+117+ 95+65 bp, respectively.
Statistical analysis
The frequency of the genotypes in patients and control groups were estimated by direct gene counting and then the data was analysed using SPSS version 18 (SPSS Inc., Chi cago, IL, USA). The odds ratio and p values were calculated for each allele in patient and control groups. All p values were two tailed. A p value of less than <0.05 was consid ered signifi cant with 95% confi dence interval (CI).
Results
Genotype and allele frequencies for IFN-γ gene polymorphisms
The results of genotyping for the patients with Pulmonary TB and controls are presented in Table Ӏ . At the IFN-γ-2109A/G polymorphic site, patient and control groups had a very similar distribution; about 85% of the A and about 15% of the G type. Genotype frequency analysis in patients showed that the largest group was comprised of/A homozygotes (66%). The A/G heterozygous group followed (31.0%), and the G/G homozygotes were rare (3%). A signifi cant difference in the allele frequency distribution between patients and controls was not observed (p value >0.05).
A comparison of the IFN-γR1-611A/G polymorphisms in patients and controls is also summarized in Table Ӏ . Based on the statistical analysis, there were statistically signifi cant differences, in genotypic frequencies, of IFN-γR1 polymorphismsbetween patients and controls (p value <0.05).
Genotype and allele frequencies for P2X7 gene polymorphisms
The frequency of the 1513A allele in the TB patients was 66.0%, whereas that of 1513 C was 34.0%, and a signifi cant differences were noted in compari-son with the frequencies in the case of the control subjects ( Table ӀӀ) . The heterozygosity (A/C) was higher in patients (66.0%) than controls: (16.0%) and the difference was statistically signifi cant (P = 0.00).
For the -762 loci, 99.0% of patients had heterozygote mutant alleles (T/C variants) and 1.0% had infrequent ho mozygote alleles (C/C). No individual car- ried the wild type (T/T) at -762 in the patients group. In general, as presented in Table ӀӀ , the frequency of P2X7 gene polymorphisms between patients and controls was statistically signifi cant (p value <0.05).
Discussion
Our study was performed to determine whether known polymorphisms of the IFN-γ, IFN-γR1 and P2X7 gene were correlated with susceptibility to TB disease in the Iranian population.
IFN-γ is the key cytokine involved in the protective response against mycobacterial infection [15] . Interferon gamma by binding with the receptor complex (IFN-γ R1) results in cellular activation. In different experimental analysis, TB patients had defi cient IFN-γ production in their peripheral blood mononuclear cells [14] . In addition, it has been shown that partial or complete loss of function alleles of IFN-γ/IFN-γR1 genes associated with various mycobacterial infections [16, 17] . In the present study, we have failed to show an association between IFN-γ-2109A/G polymorphisms and TB disease in a sample of the Iranian population (Table Ӏ) . However, IFN-γR1-611 A/G SNP allele was signifi cantly associated with increased susceptibility to TB. On the contrary to our results, Varahram et al, did not fi nd any signifi cant association between IFN-γR1-611 SNP and susceptibility to TB among Iranian studied cases [14] . Also, few studies declines the correlation of IFN-γR1 polymorphism with M. tuberculosis infection [18, 19] . At present, we have no explanation for such discrepancy, but these observations may outline the alternative pathways for enhancing host immune response against mycobacterial infections.
In present investigations, we also found two polymorphisms of P2X7 gene (-762 and -1513 ] that were signifi cantly associated with TB patients (Table  ӀӀ) . For P2X7-762 T/C SNP, T allele was more frequent in TB cases as compared to control. Previously, Bahari et al., also fi nd a positive association between P2X7-762 T/C SNP and susceptibility to TB among Iranian cases [20] . Similarly, subsequent investigation reported nearly the same observations; during 2011-2012, Singla et al. showed a positive correlation between TB and the -762 C allele [21] . However, in their analysis, only males showed a signifi cant association between P2X7-762 T/C and TB. Our results were also similar to those observed in Indian populations, and are supported by a recent meta-analysis reporting subjects with the C allele at higher risk of developing TB [22, 23] .
The P2X7-762 promoter polymorphism falls in the region where several transcription factors tend to bind [11] . Thus, sequence changes in this region may affect the activity of P2X7 receptor expression and alters its ability to regulate macrophage activity which helps in controlling TB infection [22] . Additional to 762 polymorphism, 1513 T to C allele frequency in the P2X7 gene were also investigated. We found a higher frequency of 1513 C allele in patients (34%) than control (9%) subject. Therefore, a higher risk of developing TB in individuals with hetero or homozygous allele of 1513 was highlighted. Some studies reported the importance of the 1513 C allele with pulmonary TB [24, 25] . However, the mechanisms by which these genotypes can protect the pathogenicity of TB have not been com pletely explained.
In conclusion, our study revealed a signifi cant association of IFN-γR1 and P2X7 genes polymorphisms with TB patients in Iranian population. But, no positive association was found between frequencies of IFN-γ SNPs in host and development of TB. As the genetic control of the immune response in TB seems to be polygenic, it is likely that the study of other cytokines or genes will improve our understanding of the mechanism of such a complex disease.
